Login to Your Account

Other News To Note

Tuesday, October 30, 2012
• Cellectis SA, of Paris, presented data at the European Society of Gene & Cell Therapy meeting in Versailles, France, showing that it can program cells from the immune system (T cells) to kill cancer cells. Cellectis' approach involves isolating cells from the immune systems of healthy patients and genetically programming them to attack cancer cells in sick patients.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription